EUVIMEDEUVIMED entdecken
Crossref

Off-label Use of Drugs in Childhood Asthma

António J Cabral, Mário Morais-Almeida

European Respiratory & Pulmonary Diseases · 2015

DOI: 10.17925/erpd.2015.01.01.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory & Pulmonary Diseases, 2015. Verfasst von António J Cabral und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is among the most common illnesses in childhood and may require off-label drug use for adequate symptom control. Several studies have assessed that this use is common mainly due to a lack of clinical research. The leading concerns are the increased risk of adverse drug reactions and prescription errors. However, off-label prescriptions are not necessarily incorrect. The European Medicines Agency released the Paediatric Regulation to promote research in the medicines for children; yet, recent data suggest only a minor impact.

Zitieren

APA

Cabral, A. J., & Morais-Almeida, M. (2015). Off-label Use of Drugs in Childhood Asthma. European Respiratory & Pulmonary Diseases. https://doi.org/10.17925/erpd.2015.01.01.16

Vancouver

Cabral AJ, Morais-Almeida M. Off-label Use of Drugs in Childhood Asthma. European Respiratory & Pulmonary Diseases. 2015. doi:10.17925/erpd.2015.01.01.16

BibTeX
@article{Cabral2015,
  author = {Cabral, António J and Morais-Almeida, Mário},
  title = {Off-label Use of Drugs in Childhood Asthma},
  journal = {European Respiratory & Pulmonary Diseases},
  year = {2015},
  doi = {10.17925/erpd.2015.01.01.16}
}
Kostenlos starten →